ANI Pharmaceuticals Inc (NASDAQ: ANIP). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its longer term price trend turned down, and negative upside/downside volume developed.
Small negative changes in ANI Pharmaceuticals Inc (NASDAQ: ANIP) fundamentals have recently occurred: significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
ANIP is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
ANI Pharmaceuticals has a current Value Trend Rating of C (High Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. ANI Pharmaceuticals has a neutral Appreciation Score of 49 and a slightly positive Power Rating of 67, resulting in the High Neutral Value Trend Rating.
Recent Price Action
ANI Pharmaceuticals Inc (NASDAQ: ANIP) stock closed at $59.39 on 6/20/24 after a decline of -2.2%. Moreover, trading volume in this decline was above average at 121% of normal. The stock has declined -8.5% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment